{title:`Meet the Team`,anchor:`TeamList`,placeholder:null,icon:{src:`/en-us/-/media/nebus/page-images/research-labs/menu-icons/research_icon_team.svg?rev=73efe93f0bba49709f657e78215ed5b0&hash=F698DC7DB644D50105D8C2F7E411E0DA`,alt:`Research_Icon_Team`},teamList:[{memberDescription:`

Tim did his undergraduate degrees and PhD at the University of Cambridge, supervised by Prof George Salmond, winning the Sir Howard Dalton Young Microbiologist of the Year Award in 2009 (Microbiology Society) and the Nat L. Sternberg Thesis Prize in 2011 (Cold Spring Harbor Laboratories, Phage Meeting). He then obtained an EMBO Long-Term Fellowship to join Prof James Berger's lab at the University of California-Berkeley before moving across to Johns Hopkins University School of Medicine. Arriving at Durham University in 2015, Tim won a Springboard Award in 2017 (Academy of Medical Sciences) and a Lister Institute Prize Fellowship in 2019 (Lister Institute of Preventive Medicine). He was made an Associate Professor in 2019, a Full Professor in 2022 and an Honorary Professor as of 2025. He was invited to become a Fellow of the Royal Society of Biology in 2024. In 2025 Tim moved to a Senior Scientist role at New England Biolabs, USA.

`,memberName:`Tim R. Blower`,memberTitle:`Senior Principal Investigator`,mediaSrc:`/en-us/-/media/nebus/page-images/research-labs/blower-lab/employees/tim_blower.jpg?rev=af27bc8db7be4d83be4689f9e5bf8bbd&sc_lang=en-us&hash=A488E42E2C236D9DAB81B02D9C735B64`,memberEducation:`Ph.D., University of Cambridge, UK, 2010
M.A., University of Cambridge, UK, 2009
M.Sci., University of Cambridge, UK, 2006
B.A., University of Cambridge, UK, 2005
`,memberLink:{text:``,url:``,target:`_blank`}},{memberDescription:`Ryan joined the lab in 2025 as a post-doc investigating the mechanism by which the Type IV restriction enzyme, BrxU, targets a broad range of modified DNA substrates. He completed his undergraduate studies at the University of San Diego, where he explored the role of phosphorylation in modulating the structure and function of a novel protein involved in the TLR3 signaling pathway. Ryan completed his PhD in the McLellan Lab at the University of Texas at Austin, where he leveraged structure-based vaccine design to stabilize an antigen for a potential Epstein-Barr Virus vaccine. He also used known antibodies to identify and characterize functional domains within an antigen currently used in the acellular Bordetella pertussis vaccine. Outside the lab, Ryan enjoys hiking, running, weightlifting, and has an amateur interest in brewing and learning languages.`,memberName:`Ryan McCool`,memberTitle:`Postdoctoral Fellow`,mediaSrc:`https://media.neb.com/m/2318a2e55d1d12be/webimage-Ryan_McCool_HS.png`,memberEducation:`B.A., University of San Diego, USA, 2020.
Ph.D., University of Texas, USA, 2025.
`,memberLink:{text:`linkedin.com/rsmccool`,url:`https://www.linkedin.com/in/rsmccool/`,target:`_blank`}}],moreLink:{text:`Meet the Team & Alumni`,url:`/en-us/research-labs/blower-lab/meet-the-team`,target:null}}

Choose your country

North America

Europe

Asia-Pacific